BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAK7 Class: NOTE 1.250% 5/1

LOOMIS SAYLES & CO L P's Holding History (CIK: 0000312348)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 252,345 Value ($000) $13,871 Avg Close — Range —
Q1 2025
Shares 987,865 Value ($000) $70 Avg Close — Range —
Q4 2024
Shares 1,454,656 Value ($000) $96 Avg Close — Range —
Q3 2024
Shares 2,221,448 Value ($000) $156 Avg Close — Range —
Q2 2024
Shares 2,172,135 Value ($000) $179 Avg Close — Range —
Q1 2024
Shares 2,088,044 Value ($000) $182 Avg Close — Range —
Q4 2023
Shares 2,052,945 Value ($000) $198 Avg Close — Range —
Q3 2023
Shares 2,074,551 Value ($000) $184 Avg Close — Range —
Q2 2023
Shares 2,051,316 Value ($000) $178 Avg Close — Range —
Q1 2023
Shares 2,059,347 Value ($000) $200 Avg Close — Range —
Q4 2022
Shares 2,089,754 Value ($000) $216 Avg Close — Range —
Q3 2022
Shares 2,190,467 Value ($000) $185,686 Avg Close — Range —
Q2 2022
Shares 2,274,521 Value ($000) $188,489 Avg Close — Range —
Q1 2022
Shares 2,277,794 Value ($000) $175,618 Avg Close — Range —
Q4 2021
Shares 2,304,490 Value ($000) $203,602 Avg Close — Range —
Q3 2021
Shares 2,427,099 Value ($000) $187,590 Avg Close — Range —
Q2 2021
Shares 2,366,716 Value ($000) $197,478 Avg Close — Range —